AzTrials
AzTrials

One-day Training Simulation With 4 Immersive ScenariosNCT02804425

Comparison of Learning Outcomes Between the Roles of Learner During an Immersive Simulation

A study testing actor-spectator in people with One-day Training Simulation With 4 Immersive Scenarios, run by Université Paris-Sud at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The use of simulation in medical education has been associated with positive results in the acquisition of knowledge, skills, behaviors and in patient outcome. According to Kolb et al, high-fidelity simulation provides concrete experience that is the basis for self-reflection, further experimentation and immersive… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
actor-spectator
Could I receive a placebo?
No, everyone receives an active treatment
How many people
107 participants
Where
1 siteFrance
Study dates
20 Jun 2016to Oct 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 3nd to 4rd year anesthesia (PGY3-PGY4) residents of Ile de France registered to the simulation session
  • And having agreed to participate

Who cannot join

  • Subjects incapable of giving consent: incapacitated (subjects under guardianship), minors (< 18 years)
  • Refusal to participate in the study
  • Refusal to sign the confidentiality clause

Trial locations and contacts

1 site in 1 country.

France1 site
  • Faculté de médecine Paris Sud

    Le Kremlin-Bicêtre, 94275

Other trials in France

About this study

Official title: Comparison of Learning Outcomes Between the Roles of Learner (Actor-spectator and Spectator-only) During an Immersive Simulation

The use of simulation in medical education has been associated with positive results in the acquisition of knowledge, skills, behaviors and in patient outcome. According to Kolb et al, high-fidelity simulation provides concrete experience that is the basis for self-reflection, further experimentation and immersive learning named experiential learning. However the important number of learners and the extensive human resources required to deliver mannequin patient-based simulation limit its use for initial and repeated training. In general, 2-4 trainees participate in each scenario while others may look at the progress of the scene through video transmission in a neighboring room while all trainees met thereafter for the debriefing. In typical learning sessions, all trainees act as a participant at least once. However, due to the increasing number of trainees, the investigators anticipate that some trainees might remain spectators during the whole simulation session.

In our simulation unit (LabForSIMS- Faculté de Médecine Paris Sud), a simulation session for all third to forth year anesthesia residents (PGY3-4) of Ile de France has been established a few years ago. Each session includes a one-day training with 4 different immersive scenarios using a high fidelity mannequin. Each scenario is attended by 3 residents. In years before 2014, the number of anesthesia residents to be trained was 35 and each of them could play the role of an actor at least once in the session (actor-spectator). In a previous preliminary study, the investigators found that the learning outcomes were similar for all residents at the end of the day, whatever the scenario in which they had played and those scenarios for which they had remained spectators. This led to the hypothesis that being an actor in a scenario might be less important than attending the whole session and participating in all debriefings. However, to our knowledge, few study has explored the outcomes of the learning process for spectators-only.

The number of residents sharply increased to 110 from 2014 to 2016. Due to time constraints and limitation in the number of trained teachers, the investigators see that inevitably, several trainees will remain spectators during the whole session. The purpose of this study is thus to determine whether the status of the learner (actor-spectator vs spectator-only) during an immersive simulation has an impact of learning outcomes.

Read the detailed description

Inclusions After ethical agreement, this observational single-center open study will be conducted in the simulation center of the Paris Sud medical school (LabForSIMS). After written consent, all anesthesia residents of Ile de France (PGY3-PGY4) will attend a one-day simulation session and will be included in the study. Four immersive scenarios will be performed using a high-fidelity adult mannequin (cardiac arrest, local anesthetic systemic toxicity, malignant hyperthermia and abdominal hemorrhage after trauma). Pedagogical objectives to be mastered will include both technical and non-technical skills.

Before the training session, residents will be randomized into 2 groups:

  • "actor-spectator" group (role of actor during at least one scenario in the simulation session). Three residents will participate in each scenario (one playing the role of the anesthesia resident, one playing the role of the staff physician and the third being called for help). Residents not involved in the scenario will observe the scene with direct videotransmission (role of ''spectators''). Actors and spectators will participate in all debriefings after each scenario.
  • and "spectator-only" (observer during the whole one-day session but participation in the debriefing part of the four scenarios).

Primary Outcome Measures: Evaluation of learning

  1. Satisfaction (Kirkpatrick Level 1 ) A satisfaction questionnaire will be recorded at the end of the simulation session (Likert scale (0 to 10)).
  2. Evaluation of medical knowledge (Kirkpatrick level 2) Before (pre test) and following (post test) the simulation one-day session, residents will complete a test of medical knowledge, indicating their role. This test will include 16 questions (4 questions per scenario), completed with additional questions unrelated with program training.
  3. Evaluation of non-technical skills (Kirkpatrick level 2) An auto evaluation questionnaire evaluating self perceived non-technical skills will be recorded at the end of the simulation one-day session (Likert scale (0 to 10)).
  4. Evaluation of changes in professional practice (Kirkpatrick Level 3) A questionnaire evaluating if the simulation program will modify professional practice will be recorded at the end of the simulation session (Likert scale (0 to 10)).

Secondary outcome measures: Learning retention The same questionnaire will be recorded three months after the sessions.

Being tested
actor-spectator
Keywords
Medical Education, Simulation, Anesthesia crisis management, Learning outcomes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • actor-spectatorOther

    "actor-spectator" group : actor at least once during the simulation session

Study groups in NCT02804425
Study groupRoleWhat they receive
"actor-spectator" groupExperimentalactor at least once during the immersive simulation session
Receives: Other: actor-spectator
"spectator-only" groupNo interventionobserver during the whole one-day session but participation in the debriefing part of the four scenarios

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of learning: (1) Satisfaction (Kirkpatrick Level 1 )

    A satisfaction questionnaire will be recorded at the end of the simulation session (Likert scale (0 to 10)).

    Measured: 3 months

  2. Evaluation of learning: (2) Evaluation of medical knowledge (Kirkpatrick level 2)

    Before (pre test) and following (post test) the simulation one-day session, residents will complete a test of medical knowledge, indicating their role.

    Measured: 3 months

  3. Evaluation of learning: (3) Evaluation of non-technical skills (Kirkpatrick level 2)

    An auto evaluation questionnaire evaluating self perceived non-technical skills will be recorded at the end of the simulation one-day session (Likert scale (0 to 10)).

    Measured: 3 months

  4. Evaluation of learning: (4) Evaluation of changes in professional practice (Kirkpatrick Level 3)

    A questionnaire evaluating if the simulation program will modify professional practice will be recorded at the end of the simulation session (Likert scale (0 to 10)).

    Measured: 3 months

Secondary outcomes (1)
  1. Learning retention: Evaluation of medical knowledge and non technical skills (Kirkpatrick level 2), and changes in professional practice (Kirkpatrick Level 3)

    The same questionnaire will be recorded three months after the sessions

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2016 (estimated)
  2. Study start20 Jun 2016
  3. Primary completionOct 2016
  4. Study completionOct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
107 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02804425
Sponsor's protocol ID
LabForSIMS-001
Status last verified
Nov 2018
First submitted
7 Jun 2016
Last updated
23 Nov 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: De-identified individual participant data for all participants for all primary and secondary outcomes will be available within 6 months of study completion

Questions about this trial

What is this clinical trial studying?

A study testing actor-spectator in people with One-day Training Simulation With 4 Immersive Scenarios, run by Université Paris-Sud at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of learning: (1) Satisfaction (Kirkpatrick Level 1 ) (time frame: 3 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in